Bio Elpida
Bio Elpida is a privately held French biotechnology contract development and manufacturing organization (CDMO) based in Lyon, founded in 2009, serving biotech and pharmaceutical clients with a small 11-50 person team.
- Company typePrivate
- Founded2009
- HeadquartersLyon, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
Bio Elpida firmographics
Firmographics- Name
- Bio Elpida
- Website
- https://bio-elpida.com
- Company type
- Private
- Founded year
- 2009
- Headcount range
- 11–50 employees
- Short description
- Bio Elpida is a privately held French biotechnology contract development and manufacturing organization (CDMO) based in Lyon, founded in 2009, serving biotech and pharmaceutical clients with a small 11-50 person team.
- Ownership category
- akta.pro rank
Bio Elpida industry classification
Industry- Product category
- Biopharmaceutical CDMO Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)
- akta.pro secondary industries
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)
Keywords
Where Bio Elpida is headquartered
LocationHeadquarters
- HQ city
- Lyon
- HQ country
- France
- HQ region
- Europe
Markets served
Bio Elpida business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
Bio Elpida product offering
Product offeringCore offering
Bio Elpida is a biotechnology contract development and manufacturing organization (CDMO) based in Lyon, France. It provides development and manufacturing services to biotechnology clients. Founded in 2009, the company's public website is currently under construction and redirects visitors to the Sartorius corporate site.
Differentiator
Problem solved
Functional benefit
Products and services
- Biotechnology contract development and manufacturing services
Companies that use Bio Elpida
Customer profileIdeal customer profiles1 record
Bio Elpida technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bio Elpida competitors and assessment
Company assessmentBroad incumbents
- Catalent: Catalent is a major global CDMO covering biologics, cell therapy, and fill-finish services. It is comparable to Bio Elpida on the contract development and manufacturing business model, though at vastly larger scale and broader modality coverage.
- Sartorius AG: Sartorius is a leading bioprocessing and CDMO solutions provider whose site is the redirect target from bio-elpida.com. The explicit digital handoff strongly suggests an ownership or partnership relationship, making Sartorius the most directly relevant reference peer.
- Samsung Biologics: Samsung Biologics is a top-tier biologics CDMO with large-scale mammalian drug substance and aseptic fill-finish capacity. It competes for the same biotech outsourcing programmes and serves as a scale benchmark for a small CDMO like Bio Elpida.
- Lonza Group: Lonza is the world's largest biologics CDMO offering mammalian and microbial development, drug substance and drug product manufacturing. Compared to Bio Elpida, Lonza is the full-scale incumbent benchmark for biotech contract manufacturing services globally.
- WuXi Biologics: WuXi Biologics offers end-to-end biologics development, manufacturing, and testing services globally. It is comparable to Bio Elpida as a contract development and manufacturing services provider in the biotechnology space, though operating at a much larger scale.
- Boehringer Ingelheim BioXcellence: Boehringer Ingelheim's BioXcellence business is a dedicated biologics CDMO offering contract manufacturing of mAbs and recombinant proteins, highly analogous to Bio Elpida's stated biotech CDMO scope.
- Eurofins CDMO: Eurofins operates a global CDMO and biopharma product testing network with a French presence, offering contract development, manufacturing, and quality/testing services. It is comparable to Bio Elpida on biotech contract services scope and European footprint.
Direct peers
- AGC Biologics: AGC Biologics is a mid-sized CDMO providing mammalian and microbial biologics development and manufacturing services. It is the closest mid-market scale peer to a 11-50 employee European CDMO like Bio Elpida, both targeting biotech customers with outsourced process development and GMP production.
- Rentschler Biopharma: Rentschler Biopharma is a European (German) CDMO focused on mammalian cell culture-based biologics manufacturing for biotech clients. It is directly comparable to Bio Elpida on geography (Central Europe), business model (CDMO), and biotech target customer base.
Regional players
- Novasep: Novasep is a French-headquartered CDMO with biologics, viral vectors, and small-molecule manufacturing capabilities. Its French base and contract development and manufacturing services portfolio make it a closely comparable regional peer to Bio Elpida in Lyon.
Market position
Customer concentration
Bio Elpida social profiles
Digital presenceBio Elpida financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bio Elpida leadership team
Management profileNumber of profiles
Profiles1 record
Bio Elpida funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bio Elpida M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bio Elpida
What does Bio Elpida do?
Bio Elpida is a biotechnology contract development and manufacturing organization (CDMO) based in Lyon, France. It provides development and manufacturing services to biotechnology clients. Founded in 2009, the company's public website is currently under construction and redirects visitors to the Sartorius corporate site.
When was Bio Elpida founded?
Bio Elpida was founded in 2009. It employs 11 to 50 people.
Where is Bio Elpida based?
Bio Elpida is headquartered in Lyon, France, in the Europe region.
Who are Bio Elpida's main competitors?
Broad incumbents on record are Catalent, Sartorius AG, Samsung Biologics, Lonza Group, WuXi Biologics, Boehringer Ingelheim BioXcellence and Eurofins CDMO. Direct peers are AGC Biologics and Rentschler Biopharma. Novasep is listed as a regional player.
Does Bio Elpida have an API?
No public API is recorded for Bio Elpida.
What industry is Bio Elpida in?
Bio Elpida's product category is Biopharmaceutical CDMO Services. Its primary akta.pro industry code is HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO, with a secondary code of HLAGABAG, Drug Substance–Drug Product Integrated CDMO. Its NAICS code is 541714 and its SIC code is 8731.